EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Treatment of Chronic Gastritis with Traditional Chinese Medicine: Pharmacological Activities and Mechanisms

Lisheng Chen iD, Shizhang Wei, Yong He, Xin Wang, Tingting He, Aozhe Zhang, Manyi Jing, Haotian Li, Ruilin Wang, Yanling Zhao

Pharmaceuticals · 15.09.2023 · 16 (9) · 1308

DOI: 10.3390/ph16091308 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 15.09.2023. Verfasst von Lisheng Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Program of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic gastritis (CG) is a common clinical digestive system disease, which is not easyily cured and is prone to recurrence. Traditional Chinese medicine (TCM) plays a significant role in the treatment of CG and has attracted increasing attention for clinical applications. In recent years, a large number of reports have shown that TCM has good therapeutic effect on CG. The aim of this paper is to investigate the pharmacological activities and mechanism of action of TCM in the treatment of CAG. Therefore, by searching the databases of Pubmed, China National Knowledge Infrastructure, Wanfang, and Baidu academic databases, this paper has summarized the molecular mechanisms of TCM in improving CG. The results show that the improvement of GC by TCM is closely related to a variety of molecular mechanisms, including the inhibition of Helicobacter pylori (Hp) infection, alleviation of oxidative stress, improvement of gastric function, repair of gastric mucosa, inhibition of inflammatory response, and apoptosis. More importantly, IRF8-IFN-γ, IL-4-STAT6, Hedgehog, pERK1/2, MAPK, PI3K-Akt, NF-κB, TNFR-c-Src-ERK1/2-c-Fos, Nrf2/HO-1, and HIF-1α/VEGF signaling pathways are considered as important molecular targets for TCM in the treatment of GC. These important findings will provide a direction and a basis for further exploring the pathogenesis of GC and tapping the potential of TCM in clinical treatment. This review also puts forward a bright prospect for future research of TCM in the treatment of CG.

Schlagwörter

Stichwörter der Autor:innen

active componentschronic gastritisclassical prescriptionmechanismproprietary Chinese medicine

Autor:innen und Institutionen

  • School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • Department of Pharmacy, General Hospital of PLA, Beijing 100039, China.
  • Division of Integrative Medicine, The Fifth Medical Center, General Hospital of PLA, Beijing 100039, China.

ORCID-Profile: Lisheng Chen

Förderung

  • Major Program of the National Natural Science Foundation of China

Zitieren

APA

Chen, L., Wei, S., He, Y., Wang, X., He, T., Zhang, A., Jing, M., Li, H., Wang, R., & Zhao, Y. (2023). Treatment of Chronic Gastritis with Traditional Chinese Medicine: Pharmacological Activities and Mechanisms. Pharmaceuticals, 16(9), 1308. https://doi.org/10.3390/ph16091308

Vancouver

Chen L, Wei S, He Y, Wang X, He T, Zhang A, et al. Treatment of Chronic Gastritis with Traditional Chinese Medicine: Pharmacological Activities and Mechanisms. Pharmaceuticals. 2023;16(9):1308. doi:10.3390/ph16091308

BibTeX
@article{Chen2023,
  author = {Chen, Lisheng and Wei, Shizhang and He, Yong and Wang, Xin and He, Tingting and Zhang, Aozhe and Jing, Manyi and Li, Haotian and Wang, Ruilin and Zhao, Yanling},
  title = {Treatment of Chronic Gastritis with Traditional Chinese Medicine: Pharmacological Activities and Mechanisms},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {9},
  pages = {1308},
  doi = {10.3390/ph16091308}
}
Kostenlos starten →